Patients can consume too little protein, leading to a loss of lean muscle mass during weight loss, Stanford said. They can ...

A review suggests that although obesity medications, such as GLP-1 drugs, can result in substantial weight loss, many obesity ...

Researchers say treatment decisions should be individualized by weighing expected benefits, potential harms, treatment burden ...

Considering they’re a class of drugs known for making you smaller, GLP-1 receptor agonists are only getting bigger. As many ...

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

Tirzepatide burns most fat and muscle; semaglutide cuts death, heart attack and kidney risk, and jury is out on whether they improve quality of life ...

Millions of people now take GLP-1 receptor agonist drugs such as semaglutide and liraglutide for diabetes and weight loss. A ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood pressure or heart disease.

Dr Anoop Mishra explains the benefits and side effects that weight loss injections pose for non-obese diabetics. Here is what you need to know about the mechanisms behind weight loss injections.

GLP-1 drugs like Ozempic and Wegovy have rewritten the weight-loss conversation almost overnight, but nearly everything we ...

As positive tests fall in pro cycling, concern grows over cycling’s expanding ‘grey area’ of legal medicines ...